KYVERNA THERAPEUTICS INC (KYTX) Stock Analyst Ratings

NASDAQ:KYTX • US5019761049

7.26 USD
-0.1 (-1.36%)
At close: Feb 13, 2026
7.4 USD
+0.14 (+1.93%)
After Hours: 2/13/2026, 8:21:13 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Buy % Consensus

85

ChartMill assigns a Buy % Consensus number of 85% to KYTX. The Buy consensus is the weighted average rating of the current analysts ratings.

  • Analysts have set a mean price target forecast of 28.76. This target is 296.2% above the current price.
  • KYTX was analyzed by 12 analysts. The buy percentage consensus is at 85. So analysts seem to be very confident about KYTX.
  • In the previous month the buy percentage consensus was at a similar level.
  • KYTX was analyzed by 12 analysts, which is quite many. So the average rating should be quite meaningful.

Related screens

Find peers with buy consensus above 85%
KYTX Historical Analyst RatingsKYTX Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 2 4 6 8 10

Price Target & Forecast

Price Low Median Mean High 7.2620.2030.6028.7634.65 - 178.24% 321.49% 296.20% 377.27%

Related screens

Find peers 30% below price target
KYTX Current Analyst RatingKYTX Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 2 4 6
Up and Down Grades
Date Firm Action Rating
2025-12-16 Wells Fargo Maintains Overweight -> Overweight
2025-12-04 Morgan Stanley Maintains Overweight -> Overweight
2025-10-30 Wells Fargo Maintains Overweight -> Overweight
2025-10-27 HC Wainwright & Co. Maintains Buy -> Buy
2025-10-08 Wells Fargo Maintains Overweight -> Overweight
2025-08-29 HC Wainwright & Co. Maintains Buy -> Buy
2025-08-20 William Blair Initiate Outperform
2025-05-27 HC Wainwright & Co. Upgrade Neutral -> Buy
2025-04-03 HC Wainwright & Co. Maintains Neutral -> Neutral
2025-04-01 Morgan Stanley Maintains Overweight -> Overweight
2024-11-20 HC Wainwright & Co. Maintains Neutral -> Neutral
2024-11-15 Wells Fargo Maintains Overweight -> Overweight
2024-10-10 UBS Initiate Buy
2024-09-19 HC Wainwright & Co. Reiterate Neutral -> Neutral
2024-08-15 HC Wainwright & Co. Maintains Neutral -> Neutral
2024-07-31 JP Morgan Maintains Overweight -> Overweight
2024-07-16 HC Wainwright & Co. Reiterate Neutral -> Neutral
2024-07-03 HC Wainwright & Co. Initiate Neutral
2024-03-04 JP Morgan Initiate Overweight
2024-03-04 Morgan Stanley Initiate Overweight

KYVERNA THERAPEUTICS INC / KYTX FAQ

What is the price target for KYTX stock?

12 analysts have analysed KYTX and the average price target is 28.76 USD. This implies a price increase of 296.2% is expected in the next year compared to the current price of 7.26.


What is the consensus rating for KYTX stock?

The consensus rating for KYVERNA THERAPEUTICS INC (KYTX) is 85 / 100 . This indicates that analysts generally have a positive outlook on the stock.


Can you provide the analyst count for KYVERNA THERAPEUTICS INC stock?

The number of analysts covering KYVERNA THERAPEUTICS INC (KYTX) is 12.